The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
PremiumLong Ideas - Vivus (NASDAQ:VVUS) released Monday morning that Qsymia is now commercially available as an aid for weight loss. VVUS had guided for a 4Q 2012 launch … Continue Reading
Read nowQuick Picks - On the same day that the company released exciting data from a pre-clinical stemcell experiment in rats – sending shares up more than 90% from … Continue Reading
Read nowLong Ideas - Synergy Pharmaceuticals (NASDAQ:SGYP) recently submitted an IND (Investigational New Drug application) for its IBD (inflammatory bowel disease) treatment, SP-333, and is on track to meet … Continue Reading
Read nowLong Ideas - Reports from Bloomberg that Amarin Corp. (NASDAQ:AMRN) has pulled out of the UBS Global Life Sciences Conference next week is leading some analysts to the … Continue Reading
Read nowQuick Picks - Pluristem Therapeutics (NASDAQ:PSTI) gapped down 15% Thursday morning after an announcement that the company will be raising capital through the sale of $32M in common … Continue Reading
Read nowResearch - Genzyme, a subsidiary of Sanofi (NYSE:SNY), announced Wednesday night that the FDA has approved Aubagio, its oral, once-daily treatment for Relapsing Remitting Multiple Sclerosis (RRMS). … Continue Reading
Read nowLong Ideas - Updates from two clinical trials are playing into shares of Oncolytics Biotech (NASDAQ:ONCY) Thursday morning, with some good news perking up the shares after Wednesday’s … Continue Reading
Read now
